Management of eclampsia and pre eclampsia

Reading File
Finding Sources
Finding Sources
Searching PubMed

"preeclampsia" AND "management"

Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content. Let me compile the full, detailed answer.

Management of Pre-eclampsia and Eclampsia


1. Definitions and Classification

Pre-eclampsia is hypertension (BP ≥ 140/90 mmHg on two occasions, ≥4 hours apart) arising after 20 weeks of gestation, with proteinuria or signs of end-organ damage. It is classified as:
  • Without severe features (previously "mild")
  • With severe features: BP ≥ 160/110 mmHg, thrombocytopenia (<100,000/µL), renal insufficiency (creatinine >1.1 mg/dL), impaired liver function (LFTs 2× normal), pulmonary edema, new-onset headache unresponsive to medication, or visual disturbances
Eclampsia is the occurrence of generalized tonic-clonic seizures in a woman with pre-eclampsia, in the absence of other neurological causes. Headache (83%), hyperreflexia (80%), and proteinuria (80%) are the most frequent preceding symptoms.

2. Pre-eclampsia WITHOUT Severe Features

Delivery Timing

  • ≥37 weeks: Deliver
  • 34-36+6 weeks: Expectant management with corticosteroids if appropriate; deliver no later than 37 weeks
  • <34 weeks: Expectant management with close monitoring

Monitoring During Expectant Management

  • Blood pressure and symptoms assessed at least weekly
  • Labs (CBC, LFTs, creatinine) weekly
  • Nonstress test or biophysical profile at least weekly; amniotic fluid assessment weekly; fetal growth every 3 weeks
  • Repeated proteinuria measurements are not recommended - they do not change management once the diagnosis is made

Intrapartum MgSO4

ACOG does not recommend routine magnesium sulfate for all women with pre-eclampsia without severe features. Eclamptic seizures did not occur in small placebo arms of randomized trials, though the studies were underpowered.

3. Pre-eclampsia WITH Severe Features

Delivery Timing

Gestational AgeRecommendation
≥37 weeksPrompt delivery
34-36+6 weeksDeliver; consider antenatal corticosteroids during induction if >12 hrs anticipated before delivery
<34 weeksExpectant management may be attempted if no contraindications; inpatient only
Absolute contraindications to expectant management (= deliver immediately): eclampsia, non-reassuring fetal testing, pulmonary edema, DIC, uncontrollable hypertension, placental abruption, stillbirth.

Intrapartum Magnesium Sulfate (MgSO4)

Routine parenteral MgSO4 for seizure prophylaxis is recommended in all women with severe features. Evidence base:
  • The Magpie Trial (10,000 women) proved MgSO4 reduces eclamptic seizures vs. placebo
  • MgSO4 is superior to phenytoin and superior to diazepam for both prophylaxis and treatment
Dosing:
  • Loading dose: 4-6 g IV over 15-20 minutes
  • Maintenance: 2 g/hr IV continuous infusion
Monitoring for toxicity:
  • Loss of deep tendon reflexes: first sign (~7-10 mEq/L)
  • Respiratory depression: ~10-13 mEq/L
  • Cardiac arrest: >15 mEq/L
  • Antidote: Calcium gluconate 1 g IV slowly

4. Acute Antihypertensive Therapy

Treat severe-range BP (≥160/110 mmHg) urgently to prevent maternal stroke and end-organ damage. Target: bring BP below 160/105 mmHg.
AgentDoseNotes
Hydralazine5-10 mg IV push, repeat every 2-4 hoursFirst-line in many protocols
Labetalol20 mg IV bolus, repeat every 10 min PRN up to 300 mg total doseAlso first-line; avoid in asthma
Nifedipine (oral)10-20 mg immediate-release orallyEffective; monitor for interaction with MgSO4 (potentiates neuromuscular blockade)
Sodium nitroprussideOnly if above agents failCyanide toxicity risk; short-term only
For oral maintenance antihypertensives (expectant management): labetalol, nifedipine (extended-release), or methyldopa are acceptable. Goal BP < 160/105 mmHg.

5. Management of Eclampsia (Active Seizure)

Immediate Steps (Parkland Protocol)

  1. Protect airway - left lateral decubitus position, suction if needed, supplemental O2
  2. Terminate seizure with MgSO4: 4-6 g IV over 15-20 minutes (if not already on it), then 2 g/hr maintenance
  3. Recurrent seizures on MgSO4: Give an additional 2 g IV bolus; if still seizing, consider diazepam or lorazepam
  4. Control BP after seizure control: if diastolic BP > 105 mmHg, give hydralazine 5-10 mg IV or labetalol 20 mg IV bolus
  5. Labs: CBC + platelets, LFTs, BUN/creatinine, uric acid, coagulation studies
  6. Urine output: Foley catheter; maintain ≥ 25 mL/hr
  7. IV fluids: Restrict; limit to prevent pulmonary edema. Avoid diuretics and hyperosmotic agents unless specific indication
  8. CT head: Indicated if decreased consciousness, persistent/refractory seizures, lateralizing neurological signs
  9. Initiate steps to delivery - eclampsia is an indication for delivery after maternal stabilization

6. HELLP Syndrome

A severe variant: Hemolysis, Elevated Liver enzymes, Low Platelets.
  • Confirmed by: LDH >600 U/L, AST/ALT ≥ 2× normal, platelets <100,000/µL
  • Management mirrors severe pre-eclampsia: MgSO4, BP control, delivery (expedite, especially at ≥ 34 weeks)
  • DIC may develop; procoagulant therapy before delivery if spontaneous hemorrhage risk

7. Postpartum Management

  • Approximately 1/3 of eclamptic seizures occur postpartum, most within 24 hours and almost all within 48 hours
  • Continue MgSO4 for 24 hours postpartum (standard practice); can discontinue when brisk diuresis occurs (signals resolution of pathophysiology)
  • BP may improve in first 48 hrs then worsen again at 3-6 days postpartum - monitor carefully
  • Blood pressure evaluation at 7-10 days after discharge (or earlier if symptomatic)
  • Women still hypertensive at 6 weeks postpartum may eventually normalize; long-term cardiovascular risk is elevated

8. Prevention

  • Low-dose aspirin (81 mg/day, started at 12-28 weeks, ideally before 16 weeks) is recommended for women with ≥1 high-risk factor (prior pre-eclampsia, multifetal gestation, chronic hypertension, diabetes, renal disease, autoimmune disease)
  • Calcium supplementation (1.5-2 g/day) in women with low dietary calcium intake reduces pre-eclampsia risk
  • No proven benefit from vitamins C/E, salt restriction, or bed rest in prevention

9. Summary Algorithm

Pre-eclampsia suspected
       ↓
Classify: without severe features vs. with severe features
       ↓
Without severe features:         With severe features:
- Expectant if <37 wks           - MgSO4 immediately
- Deliver at 37 wks              - IV antihypertensives if BP ≥160/110
- Weekly monitoring              - Deliver (gestational age guides timing)
- MgSO4 not routine              
       ↓
Eclampsia (seizure):
- MgSO4 4-6g load → 2g/hr
- Airway, BP control
- Labs + Foley
- CT if indicated
- Stabilize → Deliver

Sources:
  • Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice - comprehensive guidance on classification, MgSO4 dosing, antihypertensives, postpartum care
  • Rosen's Emergency Medicine - Parkland Protocol, emergency management box (Box 173.4)
  • Magpie Trial (2002): MgSO4 vs. placebo in 10,000 preeclamptic women - foundational evidence for MgSO4 use

Do all the four suggestions please

Asking for Preferences
This is a shared conversation. Sign in to Orris to start your own chat.